Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06828523 · ClinicalTrials.gov registry record · NA

Assessing Perceptual Effects of Interactive Tasks

A NA study of Amyotrophic Lateral Sclerosis, sponsored by Penn State University.

Recruiting
Registry status
NA
Development phase
1,300
Enrollment target
1
Study location

NCT06828523 is a NA study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Penn State University. The registered enrollment target is 1,300 participants, above the 885-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06828523, a NA study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Penn State University.

RECRUITING
Registry status
NA
Development phase
1,300 participants
Enrollment target
1
Study location

Study Summary

In this study, we will evaluate how solo, naive listeners perceive the speech of people with amyotrophic lateral sclerosis (ALS) and age-matched speakers produced across interactive and non-interactive contexts with an unfamiliar, naive interlocutor.

Interventions

  • BEHAVIORAL Listener judgements of speech produced in different tasks

Study Locations (1)

Pennsylvania

  • Speech Core, Pennsylvania State University - University Park

Trial Details

FieldValue
Enrollment Target 1,300 participants
Start Date 2025-10-17
Est. Completion 2029-02-28
Phase NA

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT06828523

The ClinicalTrials.gov registry entry for NCT06828523 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 885-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (47% higher). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Listener judgements of speech produced in different tasks is the first listed.

NCT06828523 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06828523 about?

NCT06828523 is a clinical study titled "Assessing Perceptual Effects of Interactive Tasks". In this study, we will evaluate how solo, naive listeners perceive the speech of people with amyotrophic lateral sclerosis (ALS) and age-matched speakers produced across interactive and non-interactive contexts with an unfamiliar, naive interlocutor.

What is the current status of trial NCT06828523?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,300 participants. The study started on 2025-10-17. Estimated completion is 2029-02-28.

What conditions does trial NCT06828523 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.

What interventions are being tested in trial NCT06828523?

The interventions under investigation include: Listener judgements of speech produced in different tasks (BEHAVIORAL).

Who is sponsoring clinical trial NCT06828523?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06828523 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.